PharmaTher - Crunchbase Company Profile & Funding

Q: Where is PharmaTher's headquarters?

PharmaTher is located in Toronto, Ontario, Canada.

Q: When was the last funding round for PharmaTher?

PharmaTher closed its last funding round on obfuscated from a Post-IPO Equity round.

Q: How much funding has PharmaTher raised to date?

PharmaTher has raised obfuscated.

Overview

PharmaTher

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About PharmaTher

CB Rank

126327

PharmaTher Holdings pecializes in the development and commercialization of ketamine-based medicines.

Founded

obfuscation

Public

Post-IPO Equity

Toronto, Ontario, Canada

1-10

www.pharmather.com/

Biotechnology

Medical

Pharmaceutical

Funding Rounds

Post-IPO Equity

OBF

obfuscation

Key People

Carmelo Marrelli: Chief Financial Officer
Fabio Chianelli: Founder, Chairman and CEO

Details

Legal Name

PharmaTher Holdings Ltd.

Also Known As

Pharmather Holdings, New scope capital, PharmaTher

Operating Status

Active

Stock Symbol

CSE:PHRM

Company Type

For Profit

Founders

Fabio Chianelli

About the Company

PharmaTher Holdings pecializes in the development and commercialization of ketamine-based medicines for mental health, neurological, and pain problems.

Phone Number

+1-888-846-3171

Predictions & Insights

Growth Insight

See this Growth Insight

PharmaTher is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Products & Services

KETARX™ (Ketamine)

A ketamine hydrochloride injection product developed for anesthesia, sedation, pain, mental health, and neurological disorders.

KetaVault™

A data portal providing access to PharmaTher's proprietary ketamine regulatory, manufacturing, and clinical data to support development and commercialization.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - PharmaTher	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - PharmaTher	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - PharmaTher	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - PharmaTher	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - PharmaTher	—	obfuscated obfuscation	—	Post-IPO Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - PharmaTher	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - PharmaTher	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - PharmaTher	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - PharmaTher	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - PharmaTher	—	obfuscated obfuscation	—	Post-IPO Equity